IL-10 leads to a higher parasite persistence in a resistant mouse model of Leishmania major infection. (Q53951136)

22 May 2018

title

IL-10 leads to a higher parasite persistence in a resistant mouse model of Leishmania major infection. (English)

1 reference

22 May 2018

1 reference

2

Michel Huerre

1 reference

22 May 2018

author name string

Alexandra Viana da Costa

1

1 reference

22 May 2018

Myriam Delacre

3

1 reference

22 May 2018

Claude Auriault

4

1 reference

22 May 2018

José Manuel Correia Costa

5

1 reference

22 May 2018

Claudie Verwaerde

6

1 reference

22 May 2018

publication date

1 December 2002

1 reference

22 May 2018

Parasitology International

published in

1 reference

22 May 2018

volume

51

1 reference

22 May 2018

issue

4

1 reference

22 May 2018

page(s)

367-379

1 reference

22 May 2018

Regulation of immunity to parasites by T cells and T cell-derived cytokines

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

1 reference

7 January 2021

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

Selective regulation of ICAM-1 and major histocompatibility complex class I and II molecule expression on epidermal Langerhans cells by some of the cytokines released by keratinocytes and T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

Differential effects of IL-4 and IL-10 on IL-2-induced IFN-γ synthesis and lymphokine-activated killer activity

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

Interleukin-10 inhibits antimicrobial activity against Leishmania major in murine macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

The role of IL-10 in promoting disease progression in leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

Interleukin 10 production correlates with pathology in human Leishmania donovani infections

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

Potential role for interleukin-10 in the immunosuppression associated with kala azar

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

T-cell response in human leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

A limiting dilution assay for quantifying Leishmania major in tissues of infected mice

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

Evolution of lesion formation, parasitic load, immune response, and reservoir potential in C57BL/6 mice following high- and low-dose challenge with Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

IL-10 mediates susceptibility to Leishmania donovani infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

Macrophage deactivation by interleukin 10

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

Interleukin-10 and the interleukin-10 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

Leishmania major reaches distant cutaneous sites where it persists transiently while persisting durably in the primary dermal site and its draining lymph node: a study with laboratory mice

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

Experimental Leishmania major infection in mice: role of IL-10

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

Altered immune responses in interleukin 10 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

IL-10 AND IL-12 ARE THE MAIN REGULATORY CYTOKINES IN VISCERAL LEISHMANIASIS

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

Recurrent cutaneous leishmaniasis: a role for persistent parasites?

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900039-9

7 January 2021

10.1016/S1383-5769(02)00039-9

Identifiers

DOI

1 reference

22 May 2018

1 reference

22 May 2018